事項 |
平成16年度 予算額 |
平成17年度 予算額(案) |
対前年度 差引 増△減額 |
対前年度 比率(%) |
備考 |
[一般行政に必要な経費] |
17,849 |
16,854 |
△ 995 |
94.4% |
|
厚生科学事務処理費 |
1,554 |
1,412 |
△ 142 |
90.9% |
|
厚生科学国際研究協力推進費 |
5,379 |
5,077 |
△ 302 |
94.4% |
|
健康危機管理推進費 |
10,916 |
10,365 |
△ 551 |
95.0% |
|
|
|
|
|
|
|
[審議会等に必要な経費] |
11,033 |
10,313 |
△ 720 |
93.5% |
|
厚生科学審議会費 |
11,033 |
10,313 |
△ 720 |
93.5% |
|
|
|
|
|
|
|
[科学技術の試験研究に必要な経費] |
42,210,885 |
42,301,339 |
90,454 |
100.2% |
|
日米医学協力研究事業委託費 |
171,214 |
0 |
△ 171,214 |
0.0% |
事業の見直し、厚生労働科学研究費補助金に統合 |
研究評価推進事業費 |
76,027 |
63,949 |
△ 12,078 |
84.1% |
|
|
|
|
|
|
|
厚生労働科学研究費補助金 |
41,963,644 |
42,237,390 |
273,746 |
100.7% |
|
|
|
|
|
|
|
|
2,655,461 |
1,332,726 |
△ 1,322,735 |
50.2% |
|
|
|
|
|
|
|
|
914,722 |
964,465 |
49,743 |
105.4% |
|
|
766,194 |
658,927 |
△ 107,267 |
86.0% |
|
|
31,971 |
27,495 |
△ 4,476 |
86.0% |
|
|
45,026 |
206,512 |
161,486 |
458.7% |
日米医学協力を含めた国際研究協力の充実 |
|
71,531 |
71,531 |
0 |
100.0% |
|
|
1,740,739 |
368,261 |
△ 1,372,478 |
21.2% |
間接経費を各研究経費に振替 |
|
|
|
|
|
|
|
9,411,306 |
10,588,647 |
1,177,341 |
112.5% |
|
|
|
|
|
|
|
|
7,295,310 |
8,502,164 |
1,206,854 |
116.5% |
|
|
3,454,233 |
3,598,116 |
143,883 |
104.2% |
|
|
3,111,889 |
3,272,889 |
161,000 |
105.2% |
|
|
662,000 |
660,676 |
△ 1,324 |
99.8% |
|
|
2,479,077 |
3,130,327 |
651,250 |
126.3% |
ナノテクノロジー等の応用 |
|
700,000 |
1,113,045 |
413,045 |
159.0% |
新たな医療機器開発の推進 |
|
2,115,996 |
2,086,483 |
△ 29,513 |
98.6% |
|
|
1,033,996 |
1,004,483 |
△ 29,513 |
97.1% |
|
|
1,082,000 |
1,082,000 |
0 |
100.0% |
|
|
|
|
|
|
|
|
19,207,690 |
20,922,283 |
1,714,593 |
108.9% |
|
|
|
|
|
|
|
|
2,063,345 |
2,077,291 |
13,946 |
100.7% |
老化抑制機構の解明、介護予防の推進 |
|
1,161,122 |
1,013,325 |
△ 147,797 |
87.3% |
|
|
738,251 |
645,123 |
△ 93,128 |
87.4% |
|
|
422,871 |
368,202 |
△ 54,669 |
87.1% |
|
|
4,633,227 |
4,864,889 |
231,662 |
105.0% |
最先端科学を活用したがん研究の推進 |
|
2,859,707 |
3,015,481 |
155,774 |
105.4% |
|
|
1,773,520 |
1,849,408 |
75,888 |
104.3% |
|
|
1,298,051 |
2,177,429 |
879,378 |
167.7% |
糖尿病等の生活習慣病対策の推進 |
|
853,474 |
847,270 |
△ 6,204 |
99.3% |
|
|
311,930 |
305,691 |
△ 6,239 |
98.0% |
|
|
541,544 |
541,579 |
35 |
100.0% |
|
|
4,211,273 |
4,526,317 |
315,044 |
107.5% |
SARS・鳥インフルエンザ等の感染症対策等の推進 |
|
1,713,391 |
1,917,175 |
203,784 |
111.9% |
|
|
1,755,352 |
1,816,601 |
61,249 |
103.5% |
|
|
742,530 |
792,541 |
50,011 |
106.7% |
|
|
1,104,815 |
1,139,546 |
34,731 |
103.1% |
|
|
1,756,175 |
2,037,398 |
281,223 |
116.0% |
こころの健康問題への取組の推進 |
|
2,126,208 |
2,238,818 |
112,610 |
105.3% |
|
|
|
|
|
|
|
|
10,689,187 |
9,393,734 |
△ 1,295,453 |
87.9% |
|
|
|
|
|
|
|
|
2,527,836 |
1,996,991 |
△ 530,845 |
79.0% |
|
|
1,717,936 |
1,432,231 |
△ 285,705 |
83.4% |
|
|
308,149 |
282,552 |
△ 25,597 |
91.7% |
|
|
4,985,419 |
4,495,396 |
△ 490,023 |
90.2% |
|
|
1,482,073 |
1,351,698 |
△ 130,375 |
91.2% |
|
イ. |
医薬品・医療機器等レギュラトリーサイエンス総合研究経費 |
|
1,454,792 |
1,277,975 |
△ 176,817 |
87.8% |
|
|
2,048,554 |
1,865,723 |
△ 182,831 |
91.1% |
|
|
1,149,847 |
1,186,564 |
36,717 |
103.2% |
有効性の高い健康診査の推進 |
|
|
|
|
|
|
合計 |
42,239,767 |
42,328,506 |
88,739 |
100.2% |
|
|